Sexual Dysfunction Before and after Treatment of Infrarenal Aortic Aneurysm Patients.


Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
Oct 2021
Historique:
received: 17 11 2020
revised: 17 03 2021
accepted: 20 03 2021
pubmed: 28 4 2021
medline: 27 1 2022
entrez: 27 4 2021
Statut: ppublish

Résumé

Sexual dysfunction is supposed to be one major complication after treatment of infrarenal aortic aneurysms. It is still controversial how many patients suffer from a sexual dysfunction already before their operation and if there are any procedure-specific differences in postoperative sexual function depending on the operative procedure performed, for example, open (OAR) or endovascular aortic repair (EVAR). To answer these questions we conducted this prospective unicentric study using the International Index of Erectile Function (IIEF) and analyzed the sexual function of 56 male patients with an infrarenal aortic aneurysm before as well as 3, 6, and 12 months after their operation. 23 patients (median age 66.5 years) were treated by OAR and 33 patients (median age 75.8 years) by EVAR. We observed that the majority of the 56 patients analyzed (91.3% of the 23 OAR patients and 96.8% of the 33 EVAR patients) suffered from a sexual dysfunction already before their operation. A 56.5% of the OAR patients and 67.7% of the EVAR patients even disclaimed a severe sexual dysfunction prior to surgery. Age and operation method showed no significant influence on the IIEF score (P= 0.647 and P= 0.621, respectively). The change of the IIEF score over the 4 time points also did not significantly differ for age and operation method (P= 0.713 and P= 0.624, respectively). The IIEF scores were significantly different between time points T1 and T4 (P= 0.042), whereas between the other time points no significant differences were found. Sexual dysfunction is very common in infrarenal aortic aneurysm patients even before their operation. OAR and EVAR do not cause a procedure-specific deterioration of the sexual function.

Identifiants

pubmed: 33905858
pii: S0890-5096(21)00349-6
doi: 10.1016/j.avsg.2021.03.045
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

318-324

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Andreas Bayer (A)

Institute of Anatomy, Christian-Albrechts-University of Kiel, Kiel, Germany. Electronic address: a.bayer@anat.uni-kiel.de.

Mark Kaschwich (M)

Department of Vascular Medicine, University Heart Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Amke Caliebe (A)

Institute of Medical Informatics and Statistics, University Hospital of Schleswig-Holstein, Kiel, Germany.

Rouven Berndt (R)

Department of Heart- and Vascular Surgery, University Hospital of Schleswig-Holstein, Kiel, Germany.

Rene Rusch (R)

Department of Heart- and Vascular Surgery, University Hospital of Schleswig-Holstein, Kiel, Germany.

Julian Pfarr (J)

Department of Radiology and Neuroradiology, University Hospital of Schleswig-Holstein, Kiel, Germany.

Jost Philipp Schäfer (JP)

Department of Radiology and Neuroradiology, University Hospital of Schleswig-Holstein, Kiel, Germany.

Jochen Cremer (J)

Department of Heart- and Vascular Surgery, University Hospital of Schleswig-Holstein, Kiel, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH